Description

BSE lists Rs. 250 crore commercial paper issued by Julius Baer Capital (India) Private Limited with redemption date of November 30, 2026.

Summary

BSE has listed new Commercial Paper issued by Julius Baer Capital (India) Private Limited on a private placement basis. The instrument consists of 5,000 units with a face value of Rs. 5,00,000 each (total Rs. 250 crore), issued at a discount of Rs. 4,66,114.50 per unit. The commercial paper is rated CRISIL A1+ and ICRA A1+, with allotment date December 3, 2025 and redemption on November 30, 2026. Trading commenced on BSE Debt segment effective December 3, 2025.

Key Points

  • Scrip Code: 730692, Scrip ID: JBC031225, ISIN: INE824H14SY5
  • Total issue size: Rs. 250 crore (5,000 units × Rs. 5,00,000)
  • Issue price: Rs. 4,66,114.50 per unit (discount of Rs. 33,885.50)
  • Credit ratings: CRISIL A1+ and ICRA A1+
  • Tenure: Approximately 362 days (December 3, 2025 to November 30, 2026)
  • Market lot: 1 unit, standard denomination: Rs. 5 lakhs and multiples
  • Tick size: 1 paise
  • Trading only in dematerialized form
  • Issuing and Paying Agent: HDFC Bank Limited

Regulatory Changes

No regulatory changes introduced.

Compliance Requirements

  • Trading members must trade the securities only in dematerialized form under ISIN INE824H14SY5
  • Trading must be conducted in standard denomination of Rs. 5 lakhs and multiples thereof
  • Minimum tick size of 1 paise must be maintained

Important Dates

  • Listing Date: December 3, 2025
  • Allotment Date: December 3, 2025
  • Redemption Date: November 30, 2026

Impact Assessment

This is a routine debt instrument listing with minimal market impact. The commercial paper provides short-term funding for Julius Baer Capital (India) Private Limited at competitive rates given the A1+ ratings. The listing expands debt market offerings but has no direct impact on equity markets or retail investors. Trading members dealing in debt securities can access this instrument for their clients’ portfolios.

Impact Justification

Routine debt instrument listing with no impact on equity markets or broader market participants